Key statistics
Short selling activityProvided by S&P Global Market Intelligence
| Open | -- |
|---|---|
| High | -- |
| Low | -- |
| Bid | -- |
| Offer | -- |
| Previous close | -- |
| Average volume | -- |
|---|---|
| Shares outstanding | 41.10m |
| Free float | 40.30m |
| P/E (TTM) | 45.54 |
| Market cap | 872.96m USD |
| EPS (TTM) | 0.4664 USD |
Data delayed at least 15 minutes.
More ▼
- Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Pacira BioSciences Appoints Samit Hirawat, M.D., to Board of Directors
- Pacira Announces Agreement with LG Chem to Make EXPAREL® Available in Select Asian-Pacific Markets
- Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Revenues
- Pacira BioSciences to Present at the 44th Annual J.P. Morgan Healthcare Conferences
- Pacira Biosciences Joins PROBE Consortium to Transform Osteoarthritis Research and Care
- Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Pacira BioSciences Announces Results From 12-Month Pilot Study Demonstrating Favorable Safety and Significant Improvements in Pain With iovera° Compared to Radiofrequency Ablation in Chronic Low Back Pain
- Pacira BioSciences Files EXPAREL® Patent Infringement Lawsuits Against The WhiteOak Group and Qilu Pharmaceutical
- Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences
More ▼
